Many have asked about
the efficacy of LDN to treat patients with Multiple Sclerosis for decades
now. Finally, here is an article that looks at the various clinical
trials that have been done over the years and the outcomes of those.
the efficacy of LDN to treat patients with Multiple Sclerosis for decades
now. Finally, here is an article that looks at the various clinical
trials that have been done over the years and the outcomes of those.
Please be aware that LDN
needs to be prepared at a formulating pharmacy and is not covered by any
insurances currently. A three month supply is around $60-$80 USD and
people who will be responders to this therapy generally report noticing a
difference (even if only a greater sense of well being) within the first week
of dosing. The first study noted in the article found at the above link
looked at 40 patients with Primary Progressive Multiple Sclerosis (PPMS) for
which we currently do not have any good ways to treat. It noted that
spasticity was less in those in the trial when the trial concluded than in those
not on the active medicine.
needs to be prepared at a formulating pharmacy and is not covered by any
insurances currently. A three month supply is around $60-$80 USD and
people who will be responders to this therapy generally report noticing a
difference (even if only a greater sense of well being) within the first week
of dosing. The first study noted in the article found at the above link
looked at 40 patients with Primary Progressive Multiple Sclerosis (PPMS) for
which we currently do not have any good ways to treat. It noted that
spasticity was less in those in the trial when the trial concluded than in those
not on the active medicine.
This drug as a
considerable amount of anecdotal information (patient stories of how they have
been helped) but very few clinical trials looking at symptom management or
actual disease modification with this drug. If you have used LDN or would
like to see more extensive clinical trials involving this, please log into www.iConquerMS.org and let them know that
you want to see trials developed that will bring this into the main line treatment
arena if it actually belongs there.
considerable amount of anecdotal information (patient stories of how they have
been helped) but very few clinical trials looking at symptom management or
actual disease modification with this drug. If you have used LDN or would
like to see more extensive clinical trials involving this, please log into www.iConquerMS.org and let them know that
you want to see trials developed that will bring this into the main line treatment
arena if it actually belongs there.
Be well,
Cherie C. Binns RN BS
MSCN
MSCN
~~~~~~~~~~~~~~~~~~~~
.
.
.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews